Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
24 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2026
STERIS from Watermaal-Bosvoorde, company number BE0440556578, closed financial year 2026 with a result of € 616,297 after tax. For that financial year STERIS recorded revenue of € 17.9 million and equity of € 951,930. Compared with financial year 2025, the result moved from € 504,676 to € 616,297. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on November 9, 2026.
€ 951,930
▼ 37% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 616,297
▲ 22% vs 2025
Profit after tax over the fiscal year.
€ 4.2 million
▼ 2% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 1.2 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2026
20.5
▲ 4.3 vs 2025
Average over the fiscal year, from the social balance sheet.
€ 2.5 million
▲ 11% vs 2025
€ 121,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 7.3 million
▲ 20% vs 2025
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 160 days on average.
€ 996,743
▲ 38% vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Revenue | € 10,896,632 | € 14,244,438 | € 14,079,958 | € 17,949,091 | ▲ 27% |
| Profit after taxes | € 637,621 | € 264,328 | € 504,676 | € 616,297 | ▲ 22% |
| Equity | € 2,246,426 | € 1,010,632 | € 1,515,308 | € 951,930 | ▼ 37% |
| Total debts | € 6,154,076 | € 11,070,913 | € 11,688,692 | € 15,211,903 | ▲ 30% |
| Cash | € 3,250,256 | € 2,012,551 | € 4,243,472 | € 4,170,780 | ▼ 2% |
| Retained profit | € 1,942,757 | € 706,962 | € 1,211,638 | € 648,260 | ▼ 46% |
| Dividend | € 0 | € 1,500,122 | € 0 | € 1,179,675 | |
| Balance sheet total | € 8,400,503 | € 12,081,545 | € 13,204,000 | € 16,163,832 | ▲ 22% |
| Employees (FTE) | 9.2 | 16 | 16.2 | 20.5 | ▲ 4.3 |
By revenue, STERIS ranks 4th of 4 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Watermaal-Bosvoorde that publish figures (fiscal year 2026).
Key figures of STERIS, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about STERIS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to STERIS?
What happened at STERIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Karen BURTON stepped down as director. NBB
- Allan ROWLEY stepped down as director. NBB
- John Patrick UBBING stepped down as director. NBB
- New annual accounts for financial year 2026: profit of € 616,297 (▲ 22% vs 2025). filed late Source: NBB ↗
- Michael Joseph TOKICH stepped down as director. NBB
- Karen BURTON became a director. NBB
- Michael Joseph TOKICH became a director. NBB
- Allan ROWLEY became a director. NBB
In short
From € 637,621 profit in 2023 to € 616,297 profit in 2026.
Paid € 794,788 in corporate taxes since 2023.
Best year ever: 2023, with € 637,621 profit.
Paid out € 2.7 million in dividends to the owners in total.
Management
The shares are held by STERIS HOLDING SA (100%) and STERIS DEUTSCHLAND SPRL (0%).
Directors
According to the 2026 annual accounts
John Patrick UBBING
Director
since 2022 · until 2028
Allan ROWLEY
Director
since 2024 · until 2029
Michael Joseph TOKICH
Director
since 2024 · until 2025
Karen BURTON
Administrateur
since 2025 · until 2031
Shareholders
STERIS HOLDING SA
100%
STERIS DEUTSCHLAND SPRL
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Terhulpsesteenweg 177 box 11
1170 Watermaal-Bosvoorde
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
All companies at this address →Euroconseils
€ -776 gross margin · 2025
Chanic
€ 126,443 gross margin · 2025
VISHA
€ 164,650 gross margin · 2025
International Beverages Corporation
€ 23.4 million revenue · 2025
Pro Familia
+19 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Watermaal-Bosvoorde
Same main activity (Groothandel in farmaceutische en medische artikelen), 5 active companies in Watermaal-Bosvoorde, largest first.
€ 506.5 million revenue · 2025
€ 86.2 million revenue · 2025
€ 52.7 million revenue · 2025
€ 55,217 gross margin · 2024
Details
- Company number
- 0440.556.578
- VAT number
- BE 0440.556.578
- Registered office
- Terhulpsesteenweg 177 bus 11, 1170 Watermaal-Bosvoorde
- Names & denominations
- STERIS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 April 1990
- Peppol
- Active · Active since 15 Sept 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten